Pazopanib in Combination With Capecitabine in Patients With Metastatic Breast Cancer

NCT01498458 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Pazopanib plus capecitabine

Sponsor

GBG Forschungs GmbH